Acronym
MoST 9 (substudies 21-22)
Project Title
Single arm, open label, signal seeking, phase II trial of the activity of tucatinib plus trastuzumab in patients with tumours harbouring HER2 amplifications or mutations
Principal Investigator
Start Date
December 11, 2019
Keywords
Cancer/HER2 amplifications or mutations
Project Type
Interventional/Clinical trials research
